Skip to main content

Reata Pharmaceuticals Inc

RETADelisted Sep 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001358762

Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Reata Pharmaceuticals Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
151
−30 vs. Q3 2021
Shares held
26.7M
+22.9K (+0.1%) vs. Q3 2021
Total value
$704.3M
−$1.98B (−73.8%) vs. Q3 2021
New holders
34
49 more added
Sold out
64
49 more reduced

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RETA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 151 institutions
Q1 2021: 201 institutionsQ2 2021: 195 institutionsQ3 2021: 183 institutionsQ4 2021: 151 institutionsQ1 2022: 149 institutionsQ2 2022: 147 institutionsQ3 2022: 159 institutionsQ4 2022: 168 institutionsQ1 2023: 205 institutionsQ2 2023: 214 institutionsQ3 2023: 2 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $704.3M
Q1 2021: $2.52BQ2 2021: $3.76BQ3 2021: $2.69BQ4 2021: $704.3MQ1 2022: $884.1MQ2 2022: $841.1MQ3 2022: $706.1MQ4 2022: $1.14BQ1 2023: $2.58BQ2 2023: $3.21BQ3 2023: $2.98MQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RETA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20232$2.98M
Q2 2023214$3.21B
Q1 2023205$2.58B
Q4 2022168$1.14B
Q3 2022159$706.1M
Q2 2022147$841.1M
Q1 2022149$884.1M
Q4 2021151$704.3M
Q3 2021183$2.69B
Q2 2021195$3.76B
Q1 2021201$2.52B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Reata Pharmaceuticals Inc; share changes are against Q3 2021.

Institutions holding RETA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
STRS Ohio0$00.00%−1,400−100.0%Sold out
Sofos Investments, Inc.0$00.00%0Sold out
Penserra Capital Management LLC0$00.00%−720−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−646−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−414−100.0%Sold out
Stonehage Fleming Financial Services Holdings Ltd0$00.00%−350−100.0%Sold out
Glassman Wealth Services0$00.00%−65−100.0%Sold out
Signaturefd, LLC0$00.00%−35−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−26−100.0%Sold out
Bellevue Asset Management, LLC0$00.00%−29−100.0%Sold out
JFS Wealth Advisors, LLC0$00.00%−24−100.0%Sold out
Meeder Asset Management Inc0$00.00%−11−100.0%Sold out
Parkside Financial Bank & Trust0$00.00%−9−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−4−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−2−100.0%Sold out
First Mercantile Trust Co––––Not filed
Berman Capital Advisors, LLC––––Not filed